FIGURE

Fig. 3

ID

ZDB-FIG-220722-5

Publication

Rusnati et al., 2021 - Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin

Other Figures

All Figure Page

Back to All Figure Page

Fig. 3

Effect of UniPR1331 on VEGFR2 activation.

The indicated cells were left unstimulated or stimulated with 10 ng/ml VEGF (a, b) or 30 ng/ml FGF2 (c) with UniPR1331 (30 μM in a–c or increasing concentrations in b). Then, cells were analyzed by WB with anti-P-VEGFR2 (a, b) or anti-P-FGFR1 (c) antibody. Uniform loading was confirmed with anti-VEGFR-2 or anti-tubulin antibody. The results shown are representative of other two that gave similar results. The single lanes have been cropped and reorganized for an easy comparison. b Densitometric quantification of P-VEGFR2 immunoreactive bands normalized to the expression levels of VEGFR2. (mean ± S.E.M. of three independent experiments, *P < 0.005).

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Cancer Gene Ther.